Mental state · schizophrenia
1 finding from 1 review
Global state ‐ number of participants with relapse/exacerbations of psychosis (separated time points) ‐ < 12 months · schizophrenia
It is very uncertain whether summary of findings table ‐ CBT without antipsychotics changes global state ‐ number of participants with relapse/exacerbations of… compared with antipsychotics (very low certainty).
1 finding from 1 review
Leaving the study early/ loss to · schizophrenia
It is very uncertain whether summary of findings table ‐ CBT without antipsychotics changes leaving the study early ‐ for any reason ‐ overall acceptability… compared with antipsychotics (very low certainty).
1 finding from 1 review
Level of functioning · schizophrenia
1 finding from 1 review
Physical aggression · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Specific behaviour ‐ agitation · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Adverse events: Clinically important effect · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Self harm ‐ frequency of self harm · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Mental state: clinically important change in mental state · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Leaving the study early · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Quality of life: clinically important change in quality of life · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Response to treatment (medium term) Clinically important response to treatment as defined by each study · people with treatment‐resistant schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Satisfaction with treatment: leaving the study early Endpoint data (events) · people with treatment‐resistant schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mental state · people with treatment‐resistant schizophrenia
1 finding from 1 review
Functioning: clinically important change in general functioning, as defined by individual studies · people with treatment‐resistant schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Service outcomes: Hospitalisation · people with treatment‐resistant schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse event/effect(s) ‐ death · people with treatment‐resistant schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Response to treatment (medium term) Clinically important response to treatment as defined by each study · people with treatment‐resistant schizophrenia
ECT plus standard care probably leads to higher response to treatment (medium term) Clinically important response to… compared with standard care (moderate certainty).
1 finding from 1 review
Cognitive functioning (short term) ‐ memory deterioration · people with treatment‐resistant schizophrenia
It is very uncertain whether ECT plus standard care changes cognitive functioning (short term) ‐ memory deterioration compared with standard care (very low certainty).
1 finding from 1 review
Satisfaction and acceptability of treatment (medium term) ‐ leaving the study early · people with treatment‐resistant schizophrenia
It is very uncertain whether ECT plus standard care changes satisfaction and acceptability of treatment (medium term) ‐ leaving… compared with standard care (very low certainty).
1 finding from 1 review